Package advice cemiplimab (Libtayo®) for the treatment of non-small cell lung carcinoma (NSCLC)
van der Waal JM, Wijma S
Record ID 32018002679
Dutch
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2021/10/26/package-advice-cemiplimab-libtayo
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Immunological
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.